medRxiv PreprintsInternational29 October 2026
First records of Triatoma sanguisuga (Hemiptera: Reduviidae) and detection of Trypanosoma cruzi (Trypanosomatida:Trypanosomatidae) in southern New Jersey, United States
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Triatoma sanguisuga (LeConte, 1855) is the most widely distributed triatomine bug species in the United States (US), but its occurrence and association with Trypanosoma cruzi (Chagas, 1909) are poorly characterized near the northeastern margin of its reported range. We combined homeowner-submitted specimens, community-science records, targeted habitat surveys, opportunistic light-trap collections, molecular identification, and pathogen screening to characterize T. sanguisuga and Trypanosoma cruzi in New Jersey. Archived mammal blood samples from central New Jersey were also screened for Trypan
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Individualised and Time-Dependent Prediction of Recurrence After Colorectal Cancer Liver Metastases Resection6 November 2026
- Beyond Perinatal Mood: Breadth of Psychiatric Symptoms and Delay Discounting as Correlates of Mothers' Relational Reports from Pregnancy Through Adult Children6 November 2026
- Brainstem functional connectivity integrates microbiome-gut-brain signals in healthy older adults: a cross-sectional evaluation and a randomised controlled probiotic trial6 November 2026
- Effect of results-based financing on selected maternal and child health indicators in Mayuge District, Uganda: a comparative interrupted time series analysis6 November 2026
- Multidimensional deprivation and brain health in older adults in rural northern Tanzania: a cross-sectional community-based study6 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.